Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM.
Here’s what investors need to know about the announcement.
Earnings
Matinas BioPharma Hldgs reported in-line EPS of $-0.03 versus an estimate of $-0.03.
Revenue was down $62.50 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 1.29% drop in the share price the next day.
Here’s a look at Matinas BioPharma Hldgs’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Actual | -0.03 | -0.02 | -0.03 | -0.03 |
| Revenue Estimate | 1.53M | 30.00K | 20.00K | 1.02M |
| Revenue Actual | 0 | 0 | 33.33K | 62.50K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
